The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 12, 2021

Filed:

Oct. 29, 2018
Applicants:

Chi-ying Huang, Taipei, TW;

Jane Hsiao, Miami, FL (US);

Pan-chyr Yang, Taipei, TW;

Meng-hua Lee, Taipei, TW;

Inventors:

Chi-Ying Huang, Taipei, TW;

Jane Hsiao, Miami, FL (US);

Pan-Chyr Yang, Taipei, TW;

Meng-Hua Lee, Taipei, TW;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5415 (2006.01); A61K 31/549 (2006.01); A61K 31/519 (2006.01); A61K 31/555 (2006.01); A61K 31/7068 (2006.01); A61K 31/5377 (2006.01); A61K 33/24 (2019.01);
U.S. Cl.
CPC ...
A61K 31/5415 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/549 (2013.01); A61K 31/555 (2013.01); A61K 31/7068 (2013.01); A61K 33/24 (2013.01);
Abstract

The present invention relates to use of antipsychotic phenothiazine derivative for treatment of cancer. The invention also provides a use for manufacture a medicament, a pharmaceutical composition and a method for treating a cancer, and/or preventing or delaying cancer recurrence based on trifluoperazine. The invention further provides a use for manufacture a medicament, a pharmaceutical composition and a method for treating cancer based on thioridazine and its enantiomers. Additionally, the invention provides a use for manufacture a medicament, a pharmaceutical composition and a method for treating KRAS mutant NSCLC comprising thioridazine.


Find Patent Forward Citations

Loading…